August 13, 2012

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

April 27, 2012

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

May 6, 2011

The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

February 11, 2011

The Food and Drug Administration announced Friday the approval of Waltham, Mass.-based Thermo Fisher’s QMS Everolimus Immunoassay, a test that monitors the blood for levels of Novartis’ drug Zortress (everolimus).

October 31, 2010

The Food and Drug Administration has approved a cancer drug for treating tumors associated with...

May 16, 2010

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

January 25, 2010

Daniel Vasella will step down as CEO of Novartis to focus on his position as...